160
HEME : Health and Medical Journal pISSN : 2685 Ae 2772 eISSN : 2685 Ae 404x Available Online at : https://jurnal.
id/index.
php/heme/issue/view/76 The Role of Vitamin D in Immune Balance and Inflammation Kurnia Maidarmi Handayani1*.
Widia Sari2.
Ghaniyyatul Khudri3.
Alief Dhuha2 Department of Biochemistry and Nutrition.
Faculty of Medicine.
Universitas Baiturrahmah.
Padang.
Indonesia E-mail : kurnia_maidarmi@fk.
Department of Anatomy.
Physiology, and Radiology.
Faculty of Medicine.
Universitas Baiturrahmah.
Padang.
Indonesia Department of Histology and Immunology.
Faculty of Medicine.
Universitas Baiturrahmah.
Padang.
Indonesia Abstract Vitamin D, traditionally known for its role in bone health, is increasingly recognized as a crucial regulator of immune balance and inflammation.
This review explores the mechanisms by which vitamin D influences both innate and adaptive immune responses, with a focus on immune cells like macrophages, dendritic cells.
T cells, and B cells.
Vitamin D, through its active form, calcitriol, modulates immune cell function by binding to the Vitamin D receptor (VDR), which impacts cytokine production and inflammatory pathways.
Notably, vitamin D promotes anti-inflammatory effects by shifting immune responses towards a regulatory phenotype, reducing pro-inflammatory cytokines while enhancing anti-inflammatory signals.
This regulatory potential highlight vitamin DAos therapeutic value for inflammatory and autoimmune diseases.
Further research is essential to determine optimal vitamin D dosing and its implications across diverse populations.
KeywordsAi Autoimmune disease, cytokines, inflammation, immune regulation, vitamin D Health and Medical Journal HEME.
Vol VII No 2
May 2025
INTRODUCTION
Inflammation is a critical physiological response to injury or infection, playing a fundamental role in the immune system's ability to protect the body.
However, when inflammation becomes chronic, it can drive the pathogenesis of various diseases, including cardiovascular disease, diabetes, autoimmune disorders, and cancer.
This persistent state of inflammation, often referred to as "chronic low-grade inflammation," represents an ongoing immune activation that contributes to tissue Recognizing and understanding the factors that can influence chronic inflammation are key to identifying potential therapeutic targets for these widespread conditions.
Recent research has highlighted Vitamin D as a modulator of the immune system, with potential implications for inflammation Traditionally recognized for its essential role in bone health and calcium homeostasis.
Vitamin D is now understood to play a more complex role in immune regulation, particularly through its antiinflammatory properties.
The active form of Vitamin D, 1,25-dihydroxyvitamin D3 .
, influences both the innate and adaptive immune responses by regulating the production of pro- and anti-inflammatory This cytokine modulation suggests a protective role for Vitamin D against the development of chronic inflammation and related diseases.
Vitamin D exerts its immune effects through the Vitamin D receptor (VDR), which is found on numerous immune cells, including macrophages, dendritic cells, and T and B Once Vitamin D binds to VDR, it regulates gene expression related to immune responses.
This VDR-mediated mechanism helps balance pro- and antiinflammatory cytokine production, which is This regulation is particularly Email : heme@unbrah.
vital for preventing excessive immune activation, which is commonly associated with chronic inflammatory and autoimmune A study by Hewison .
discussed the critical function of VDR in immune cells, showing that activation of VDR leads to the suppression of the NF-B signaling pathway, a major regulator of inflammatory responses.
The study also indicated that the expression of VDR in immune cells is upregulated in response to infections or inflammation, suggesting that immune cells become more responsive to the anti-inflammatory effects of Vitamin D during these states.
Despite these promising insights, gaps remain in understanding the variability of VDR expression across different populations and how factors like age or pre-existing conditions affect VDR activity.
Despite this promising evidence, we aim to review the understanding of how Vitamin D impact inflammation, including macrophage signaling, dendritic cell function, and T cell Further research is needed to clarify these molecular effects and the implications of Vitamin D deficiency or supplementation on immune health and chronic inflammation across different II.
REVIEW
OVERVIEW OF VITAMIN D
Vitamin D is an essential nutrient for the Like the hormones produced by the adrenal glands and sex hormones, this vitamin also originates from steroids.
6 In addition to maintaining the balance of bones, calcium, and phosphate, vitamin D also plays a crucial role in the cardiovascular system, cancer prevention, and functions as an antiinflammatory Experts argue that vitamin D is not merely a vitamin but can also be classified as a Heme.
Vol VII No 2 May 2025 This opinion arises because vitamin D is the only vitamin that can be produced by the body and acts on target cells located far from its production site.
Furthermore, vitamin D has wide-ranging effects on the body.
Vitamin D has two different precursor molecules: vitamin D3 and vitamin D2.
Vitamin D3 .
is the primary source of vitamin D for the body, produced through sun exposure on the skinAos epidermis, from animal-based foods .
uch as fish and egg yolk.
, or from vitamin supplements (Figure .
Vitamin D2
is derived from plants and is MOLECULAR AND BIOMCHEMICAL
PATHWAY OF VITAMIN D
The process of vitamin D synthesis begins with the formation of vitamin, which is produced in the epidermis by reacting with 7-dehydrocholesterol .
-DHC) in response to ultraviolet B (UVB) radiation.
UVB rays break the B-ring of 7-DHC, forming previtamin D .
re-D.
Subsequently, pre-D3 is isomerized to form vitamin D3.
This process is non-catalytic and thermosensitive (Figure 5Ae7 The production of vitamin D in the epidermis is significantly influenced by the intensity of UVB exposure, as well as factors such as altitude and seasons.
8,9 Skin pigmentation, significantly affect vitamin D production.
Melanin concentration in the skin inhibits UVB rays from penetrating 7-DHC, consequently diminishing vitamin D Black clothing and sunscreen reduce UVB penetration to the skin, thereby impacting vitamin D synthesis.
Black cotton clothing effectively blocks around 98.
6% of UVB rays, whereas sunscreen functions by reflecting or absorbing UVB, thereby preventing its penetration to the skin.
Vitamin D synthesis is influenced not only by sunlight exposure but also by the availability of 7-DHC, which is contingent upon the activity of the enzyme 7 Dehydrocholesterol Reductase (DHCR.
reduction in the activity of this enzyme may enhance vitamin D synthesis and decrease cholesterol production.
5 Dietary sources of vitamin D include eggs, fish, liver, and milk, as well as supplements that provide vitamin D3 or D2 directly.
FIGURE 1.
VITAMIN D METABOLISM
The metabolism of vitamin D involves two hydroxylation mechanisms occurring in the liver and kidneys.
These processes are facilitated by cytochrome P450 mixedfunction oxidases (CYP.
, which are present Health and Medical Journal HEME.
Vol VII No 2 May 2025 in the endoplasmic reticulum and In the liver, vitamin D hydroxylation to form 25-hydroxyvitamin D .
OHD).
Thereafter, 25OHD undergoes 1,25dihydroxyvitamin D .
,25(OH)CCD) in the kidneys (Fig.
hydroxylates calcitriol into an inactive form.
The catabolism of calcidiol and calcitriol occurs via 24-hydroxylation and 23hydroxylation pathways.
These pathways produce inactive calcitroic acid and 26,23lactone, the final metabolites of vitamin D metabolism, which are eliminated from the body through bile or urine.
5,8,9
Vitamin D produced in the skin passes through the bloodstream and binds to the vitamin D binding protein (DBP) for circulation in the blood.
In the liver.
Vitamin D is hydroxylated through the action of the CYP2R1.
CYP27A1.
CYP2D25.
These enzymes hydroxylate vitamin D at the C-25 position, producing 25-hydroxyvitamin D .
OHD), commonly referred to as calcidiol.
Calcidiol acts as a biomarker for serum vitamin D levels, as it is the primary circulating form of vitamin D in the blood.
Almost all forms of vitamin D are transported in the bloodstream by associating with vitamin D binding protein (DBP).
DBP
shows a greater affinity for 25(OH)D than for 1,25(OH)CCD, contributing to the predominance of 25(OH)D in circulation.
Approximately 15% of vitamin D is bound to albumin, whereas only about 0.
03% of 25(OH)D and approximately 0.
4% of 1,25(OH)CCD circulate freely in the The transfer of vitamin D from the bloodstream to target cells is mediated by receptors that can identify the vitamin DDBP complex.
Calcidiol produced in the liver reaches the circulatory system.
As the blood passes through the glomerular capillaries, calcidiol is filtered by the renal glomerulus and reabsorbed in the renal tubules.
Calcidiol undergoes hydroxylation in the renal tubules, mediated by the enzyme CYP27B1, the only 1-hydroxylase responsible for vitamin D hydroxylation in the kidneys, primarily located in the proximal tubules.
This enzyme hydroxylates 25(OH)D at the C-1 position of the A-ring, resulting in the active form of vitamin D, known as 1,25-dihydroxyvitamin D .
,25(OH)CCD), also referred to as calcitriol.
The conversion of vitamin D, from its original produced form in the skin to its active form, occurs not only in the liver and kidneys but also in other parts of the body.
Calcidiol can be hydroxylated into its inactive form in the kidney's proximal tubules in addition to being hydroxylated into its active form.
The catabolic enzyme CYP24A1 facilitates this inactivation CYP24A1 not only hydroxylates calcidiol into its inactive state but also Email : heme@unbrah.
MODULATION OF VITAMIN D IN
INFLAMMATION
VITAMIN D AND ITS ROLE IN IMMUNE
MODULATION
Vitamin D is increasingly recognized for its role in immunomodulation and inflammation regulation, primarily through its active form, 1,25-dihydroxyvitamin DCE .
,25(OH)CCDCE or Calcitriol binds to the vitamin D receptor (VDR) expressed on various immune cells, including macrophages, dendritic cells, and T and B lymphocytes, initiating a series of molecular signaling pathways that impact both innate and This modulates gene expression and cellular functions, resulting in reduced production of pro-inflammatory cytokines, such as interleukin-6 (IL-.
and tumor necrosis factor-alpha (TNF-), and promoting an antiinflammatory immune response.
This regulatory effect of Vitamin D is particularly crucial in preventing immune overactivation.
Heme.
Vol VII No 2 May 2025 which can lead to chronic inflammation and the development of autoimmune conditions.
Health and Medical Journal HEME.
Vol VII No 2 May 2025 Vitamin supplementation reduced inflammatory markers in patients with metabolic syndrome, suggesting a systemic effect on reducing inflammation.
These findings support the hypothesis that Vitamin D has a central role in controlling inflammation by modulating immune cell activity.
11 These findings underscore the potential therapeutic value of Vitamin D in modulating immune responses and controlling inflammation.
Nevertheless, further research is needed to supplementation protocols, as responses may vary across populations, thereby refining Vitamin DAos role in immune health and inflammation management.
FIGURE 2 A.
VITAMIN D3 SYNTHESIS IN SKIN: UVB
CONVERTS 7-DEHYDROCHOLESTEROL TO PRE-D3,
WHICH THERMALLY REARRANGES INTO D3.
CONTINUED UV EXPOSURE PRODUCES
LUMISTEROL3 AND TACHYSTEROL3.
REVERSIBLE
TO PRE-D3 IN DARKNESS.
VITAMIN D METABOLISM: THE LIVER
CONVERTS D3 TO 25OHD.
AND THE KIDNEYS
FURTHER HYDROXYLATE IT TO ACTIVE
1,25(OH)CCD AND INACTIVE 24,25(OH)CCD,
REGULATED BY CALCIUM.
PHOSPHORUS.
PTH,
FGF23.
AND 1,25(OH)CCD.
EVIDENCE OF ANTI-INFLAMMATORY
EFFECTS OF VITAMIN D
Several immunomodulatory effects of Vitamin D.
study by Jeffery et al.
found that individuals with sufficient levels of Vitamin D exhibited lower levels of proinflammatory cytokines, such as interleukin6 (IL-.
and tumor necrosis factor-alpha (TNF-), compared to those with Vitamin D 10 Similarly.
Prietl et al.
Email : heme@unbrah.
MECHANISM OF VDR ACTIVATION IN
IMMUNE CELLS
The Vitamin DCE metabolite, 1,25dihydroxyvitamin DCE .
, binds to the Vitamin D receptor (VDR) at very low concentrations, activating it to regulate immune-related genes.
This VDR activation is crucial not only for cellular metabolism but also for modulating immune responses, including antimicrobial defenses and T cell In innate immunity, monocytes, macrophages, and dendritic cells use VDR signaling to produce antimicrobial peptides and promote a balanced inflammatory In adaptive immunity, calcitriol binding to VDR in T cells helps regulate proand anti-inflammatory cytokines, supporting immune homeostasis.
12 Overall.
VDR is integral to Vitamin DAos role in balancing immune responses, yet more research is needed on VDR expression variability and population-specific effects.
VDR EXPRESSION AND ITS CLINICAL
IMPLICATIONS
A study by Hewison's in 2012 highlights the essential role of VDR in immune cells, demonstrating how VDR activation can suppress the NF-B signaling pathway, a major regulator of inflammatory responses.
The study also indicated that the expression Heme.
Vol VII No 2 May 2025 of VDR in immune cells is upregulated in response to infections or inflammation, suggesting that immune cells become more responsive to the anti-inflammatory effects of Vitamin D during these states.
4 Despite these promising insights, gaps remain in understanding the variability of VDR expression across different populations and how factors like age or pre-existing conditions affect VDR activity.
MODULATION OF INNATE CELLS BY
VITAMIN D
MACROPHAGES
Vitamin D is essential for regulating macrophage differentiation and maturation, key processes that influence the functional Macrophages, monocytes circulating in the bloodstream, differentiate into their mature form upon entering tissues and responding to environmental signals.
The active form of vitamin D, 1,25-dihydroxyvitamin D3 .
, plays a critical role in guiding the phenotypic fate of macrophages, by binding to the vitamin D receptor (VDR) on It directs their differentiation into either the pro-inflammatory M1 phenotype or the anti-inflammatory M2 phenotype, depending on the immune M1 macrophages are typically associated with the production of inflammatory cytokines and reactive oxygen species (ROS), which are vital for combating pathogens and tumor cells.
Conversely.
M2 macrophages support tissue repair and the resolution of inflammation, promoting a return to homeostasis.
The role of vitamin D extends to the modulation of innate immune responses, particularly through its impact on macrophage activity.
This modulation ensures a balanced immune response: M1 macrophages engage in pathogen defense and inflammation, while M2 macrophages contribute to tissue repair and the resolution of inflammation.
Vitamin D helps regulate the balance of the immune response, ensuring that inflammation is controlled, and tissue damage is efficiently repaired.
Thus, vitamin DAos influence on macrophage polarization plays a pivotal role in both immune defense and the healing process.
Calcitriol modulates this differentiation process primarily through the Vitamin D receptor (VDR), a nuclear receptor expressed in monocytes and macrophages.
Upon binding to VDR, calcitriol influences the transcription of specific genes involved in macrophage development.
Research by Sadeghi et al.
demonstrated that Vitamin D skews macrophage differentiation toward the M2 phenotype by inhibiting the production of pro-inflammatory molecules such as inducible nitric oxide synthase .
NOS) and TNF-, which are characteristic of M1 macrophages.
Additionally, calcitriol enhances the expression of M2 markers, including CD206 .
annose recepto.
and arginase-1, both of which are essential for wound healing and tissue remodeling.
Vitamin D enhances macrophage phagocytic function, a crucial immune mechanism for engulfing and destroying pathogens, dead cells, and debris.
This effect is mediated through vitamin DAos regulation of antimicrobial peptide production and phagocytic receptor expression.
Specifically, calcitriol binding to the vitamin D receptor
(VDR)
antimicrobial peptide, as demonstrated by Liu et al.
, enhancing macrophagesAo ability to eliminate pathogens like Mycobacterium tuberculosis.
Vitamin D also increases scavenger receptor expression .
CD36 and SR-A) to aid in the clearance of apoptotic cells and oxidized lipoproteins, which is essential for preventing atherosclerosis.
Additionally, vitamin D activates the phosphoinositide 3kinase (PI3K) Health and Medical Journal HEME.
Vol VII No 2 May 2025 These collective effects highlight Vitamin D's essential role in balancing inflammation and immune defense, emphasizing its potential therapeutic value in treating chronic inflammatory and autoimmune diseases.
Despite these promising findings, further research is necessary to refine our understanding of how Vitamin D influences macrophage function across varying disease contexts and individual differences, such as age and comorbidities, for effective clinical DENDRITIC CELSS Vitamin D plays a crucial role in immune regulation by modulating the proliferation and differentiation of dendritic cells (DC.
, which are essential antigen-presenting cells responsible for processing and presenting antigens to T cells, thereby orchestrating the adaptive immune response.
However, excessive dendritic cell activity can overstimulate T cells, leading to chronic inflammation and autoimmune disorders.
Vitamin D, particularly in its active form, 1,25-dihydroxyvitamin D3 .
, has demonstrated significant immunoregulatory effects by inhibiting these processes.
Research shows that Vitamin D limits the maturation of dendritic cells from monocytes and reduces the expression of MHC class II.
CD40.
CD80, and CD86, which are essential for nayve T cell activation.
18 By inhibiting full maturation.
Vitamin D reduces the capacity of dendritic cells to activate nayve T cells, thereby enhancing immune balance and reducing the risk of excessive immune Vitamin D achieves this through its interaction with the Vitamin D receptor (VDR) on dendritic cell precursors, affecting genes involved in cell cycle control and differentiation, thereby controlling immature dendritic cell proliferation.
This effect is particularly valuable in inflammatory conditions where excessive dendritic cell proliferation could worsen the immune 19 In addition.
Vitamin DAos Email : heme@unbrah.
inhibitory effect on dendritic cell differentiation involves suppression of the NF-B pathway, which is crucial for dendritic cell activation and maturation, pro-inflammatory Recent studies have provided compelling evidence supporting the immunoregulatory effects of vitamin D on dendritic cells (DC.
The active form of vitamin D, 1,25dihydroxyvitamin DCE .
, has been shown to promote a tolerogenic phenotype in DCs by impairing their full maturation.
Vitamin D-treated DCs exhibit reduced expression of major histocompatibility complex (MHC) class II molecules and costimulatory markers such as CD80 and CD86, thereby diminishing their ability to activate nayve T cells and initiate proinflammatory responses.
Hafkamp et al.
demonstrated that vitamin DCE-primed DCs altered the balance of T cell responses by inhibiting Th17 differentiation and promoting regulatory T cell (Tre.
development in a neutrophil-dependent model, indicating a shift toward immune CYTOKINE PRODUCTION: MODULATING IL12 AND TH1 RESPONSES Vitamin D plays a pivotal role in modulating cytokine production in dendritic cells, thereby influencing T-cell differentiation and immune responses.
IL-12, a critical cytokine for driving T cell differentiation into Th1 cells, facilitates cellular immunity and proinflammatory responses.
Vitamin D inhibits IL-12 production, leading to a decrease in Th1 differentiation and inflammatory cytokines such as interferon-gamma (IFN-), inflammatory diseases like multiple sclerosis and CrohnAos disease.
Griffin et al.
demonstrated that Vitamin D downregulates the IL-12p40 subunit, an essential component of IL-12, thereby suppressing the inflammatory Th1 response.
Heme.
Vol VII No 2 May 2025 Vitamin D also influences antigen Its ability to downregulate IL-12 not only reduces T cell activation and differentiation but also results in a more controlled immune response, highlighting its role in mitigating chronic inflammation.
Furthermore.
Vitamin D enhances the production of IL-10, a potent antiinflammatory cytokine that suppresses Th1 cells and promotes immune tolerance.
fostering a balance between IL-12 and IL-10.
Vitamin D shifts the immune response toward a Th2 profile, reducing inflammation and supporting immune homeostasis TABLE 1.
MODULATION OF INNATE CELSS BY
VITAMIN D
Cell Target Differentiation Maturation Enhanced Phagocytosis Macropha Pro- and Antiges Inflammatory Cytokine Production Chemokine Modulation in Macrophage Chemotaxis Impact on Antigen Presentation Dendrit ic Cells Proliferation Differentiation Cytokine Production Immunomodulatory Effects of Vitamin D Directs differentiation into either proinflammatory (M.
or anti-inflammatory (M.
phenotypes as needed by the immune Upregulates antimicrobial peptide production, enhancing phagocytic capability.
Regulates the balance of pro- and antiinflammatory cytokines to maintain immune system homeostasis.
Influences macrophage migration towards sites of inflammation or Modulates the expression of MHC class II molecules, essential for antigen presentation to T cells.
Inhibits dendritic cell
proliferation and reducing the risk of Decreases IL-12
production, which plays a role in activating Th1
responses, thereby reducing excessive Th1
VITAMIN D IN ADAPTIVE IMMUNE
RESPONSE REGULATION
Macrophages are essential players in antigen presentation, a process by which pathogenderived peptides are displayed on cell surfaces to engage T cells, kickstarting an adaptive immune response.
Vitamin D has been shown to modulate antigen presentation in ways that shape T cell activation and, consequently, the immune response.
balanced modulation is vital.
too much antigen presentation can lead to chronic inflammation and autoimmunity, whereas inadequate presentation may compromise the immune system's ability to fight infections.
Vitamin D achieves this modulation by regulating the expression of major histocompatibility complex (MHC) class II molecules and co-stimulatory molecules on MHC class II molecules are critical for presenting antigens to CD4 T cells, and co-stimulatory molecules like CD80 and CD86 are required for complete T cell activation.
For example.
Adams et al.
found that calcitriol .
he active form of Vitamin D) reduces MHC class II expression on macrophages, which in turn decreases their T cell activation ability.
This downregulation helps to manage conditions like autoimmune diseases, where heightened T cell activity can result in tissue damage.
EFFECT ON T CELLS
Vitamin D, particularly in its active form, 1,25-dihydroxyvitamin D3 .
, exerts profound direct and indirect effects on T-cell function and differentiation, playing a pivotal role in immune modulation.
22 One of its primary direct effects is the inhibition of T-cell proliferation, a critical process in While T-cell proliferation is necessary for mounting an Health and Medical Journal HEME.
Vol VII No 2 May 2025 immune response, its dysregulation can result in chronic inflammation and Calcitriol achieves this by binding to the Vitamin D receptor (VDR) on activated T cells, regulating the transcription of cell cycle control genes.
Beyond proliferation control.
Vitamin D promotes anti-inflammatory T-cell subsets such as T helper 2 (Th.
cells and regulatory T cells (Treg.
, which are vital for maintaining immune tolerance.
Th2 cells secrete cytokines like IL-4 and IL-10, which counterbalance pro-inflammatory Th1 and Th17 responses.
Tregs further suppress excessive immune activation by enhancing immune tolerance.
Research by Daniel et al.
highlighted that Vitamin D facilitates Th2 differentiation through the upregulation of GATA3, a key transcription factor, while promoting Treg expansion by enhancing FoxP3 expression, the master regulator of Treg function.
These effects create an antiinflammatory reducing the risk of autoimmune diseases.
Vitamin D also suppresses pro-inflammatory T helper 1 (Th.
cells and their associated cytokines, such as interferon-gamma (IFN-) and IL-2, which are implicated in autoimmune diseases like multiple sclerosis Calcitriol downregulates T-bet, the transcription factor driving Th1 differentiation, and reduces IFN production, effectively mitigating Th1driven inflammation.
Cantorna et al.
showed that Vitamin D supplementation in deficient mice reduced Th1 responses and underscoring its potential in managing Th1mediated conditions.
Similarly.
Vitamin D inhibits T helper 17 (Th.
cells, which are associated with IL-17 production and chronic inflammatory diseases such as psoriasis and RORt, transcription factor, and suppressing IL-17 production.
Vitamin D reduces the inflammatory burden while promoting TregEmail : heme@unbrah.
mediated immune balance.
In addition to its direct effects on T cells.
Vitamin D modulates antigen presentation through its impact on dendritic cells, key players in T-cell activation.
By inhibiting dendritic cell maturation.
Vitamin D reduces the expression of MHC class II and costimulatory molecules, thereby limiting the activation of pro-inflammatory T-cell subsets like Th1 and Th17.
Penna et al.
demonstrated that Vitamin D-treated dendritic cells favor Treg differentiation and produce higher levels of IL-10, an antiinflammatory cytokine that suppresses Th1 and Th17 responses.
This dual regulation of dendritic cells and T cells highlights Vitamin DAos comprehensive role in maintaining immune homeostasis and preventing chronic inflammation, making it a valuable tool in managing autoimmune and inflammatory EFFECT ON B CELLS B cells, a key component of the adaptive immune system, play a critical role in producing antibodies and presenting Vitamin D, particularly its active form 1,25-dihydroxyvitamin D3 .
, exerts significant effects on B cell The process of B cell differentiation is tightly regulated, as it transitions from an immature state in the bone marrow to fully mature plasma cells that produce immunoglobulins.
Vitamin D influences this process by binding to the Vitamin D receptor (VDR), which is expressed on B cells, thereby affecting the transcription of genes involved in B cell Research by Chen et al.
demonstrated that calcitriol directly inhibits the differentiation of B cells into plasma cells, which are responsible for secreting The study found that Vitamin D reduces the expression of key transcription factors such as B lymphocyte-induced maturation protein-1 (Blimp-.
, which is Heme.
Vol VII No 2 May 2025 essential for plasma cell differentiation.
25 By inhibiting this pathway.
Vitamin D prevents the excessive production of antibodysecreting plasma cells, which is particularly relevant in autoimmune diseases where B cells often become autoreactive and produce harmful autoantibodies.
This ability of Vitamin D to modulate B cell differentiation is crucial for maintaining immune tolerance Another critical effect of Vitamin D on B cells is its ability to inhibit their B cell proliferation is necessary for the expansion of antigen-specific B cells during an immune response.
However, excessive proliferation of B cells, particularly autoreactive B cells, can lead to autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid 26 Vitamin D, through the activation of VDR on B cells, inhibits their proliferation, thereby controlling the expansion of autoreactive B cells.
Research has shown that calcitriol reduces the production of various classes of immunoglobulins, including IgG.
IgM, and IgA.
A study by Rolf et al.
demonstrated that Vitamin D directly inhibits the secretion of immunoglobulins from plasma cells by reducing the expression of immunoglobulin genes.
This effect is mediated by the downregulation of transcription factors such as Blimp-1, which are required for immunoglobulin production.
The study also found that Vitamin D reduces the production of autoantibodies in autoimmune conditions, providing a potential therapeutic mechanism for diseases such as SLE, where B cells play a central role in disease pathogenesis.
The ability of Vitamin D to reduce immunoglobulin production is particularly important in the context of autoimmunity, where uncontrolled B cell activity leads to the production of harmful antibodies.
limiting immunoglobulin synthesis.
Vitamin D helps prevent the immune system from attacking the bodyAos own tissues.
This immunosuppressive effect of Vitamin D has therapeutic potential in reducing the severity of autoimmune diseases, but it must be carefully balanced to avoid impairing protective immune responses to infections.
Studies have shown that calcitriol reduces the proliferation of B cells by regulating cell cycle progression.
Vitamin D inhibits the expression of cyclins, which are proteins required for the progression of B cells from the G1 phase to the S phase of the cell cycle.
As a result.
B cells are arrested in the G0/G1 phase, preventing their clonal expansion.
Chen et al.
also reported that Vitamin D reduces the proliferation of both nayve and memory B cells, highlighting its broad impact on B cell dynamics.
By controlling B cell proliferation.
Vitamin D limits the pool of B cells that could potentially become autoreactive and produce pathogenic B cell tolerance is also influenced by Vitamin D, which plays a role in preventing B cells from becoming autoreactive and producing autoantibodies.
During B cell development, tolerance is established through checkpoints where autoreactive B cells are either deleted or inactivated.
autoimmune diseases, these mechanisms fail, allowing autoreactive B cells to survive and Vitamin D, particularly its active form calcitriol, enhances B cell tolerance by promoting the deletion of autoreactive B cells through apoptosis and preventing their Heine et al.
showed that calcitriol upregulates pro-apoptotic genes while downregulating anti-apoptotic genes, selectively eliminating autoreactive B cells, which helps prevent autoimmune disease Additionally.
Vitamin D promotes B cell anergy, a state of unresponsiveness, where autoreactive B cells cannot activate or produce antibodies.
Health and Medical Journal HEME.
Vol VII No 2 May 2025 These findings highlight Vitamin D's potential as a therapeutic tool for restoring B cell tolerance in autoimmune diseases.
However, further research is needed to elucidate the precise molecular mechanisms by which Vitamin D regulates B cell tolerance and assess its long-term efficacy in preventing autoimmunity.
Understanding the impact of different doses and forms of Vitamin D on B cell tolerance could inform the development of personalized therapies for autoimmune patients, optimizing treatment strategies to maintain immune Vitamin DAos regulatory effects on B cells autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS), where dysregulated B cells produce pathogenic inflammation and tissue damage.
Vitamin DAos ability to inhibit B cell proliferation, production offers a potential therapeutic approach to mitigate these harmful effects.
For example, in SLE patients.
Vitamin D supplementation has been shown to reduce autoantibodies, such as anti-double-stranded DNA .
nti-dsDNA), by inhibiting B cell activity and promoting immune tolerance, as demonstrated in a clinical study by Arnson et .
These findings suggest that Vitamin D could serve as an adjunct therapy cell-mediated However, further clinical trials are needed to determine optimal dosing, duration, and the long-term safety of Vitamin D supplementation, particularly in patients with autoimmune diseases who may be more vulnerable to infections due to its immunosuppressive effects.
By preventing excessive B cell proliferation and differentiation.
Vitamin D supports immune tolerance and curbs overactive immune responses, which is essential in Overall.
Email : heme@unbrah.
immunomodulatory effects of Vitamin D on T and B cells underscore its potential as a therapeutic agent for maintaining immune homeostasis and managing autoimmune TABLE 2.
MODULATION OF ADAPTIVE IMMUNE
CELLS BY VITAMIN D.
Immunomodulatory Effects of Vitamin Reduces excessive T Inhibition of cell proliferation to T Cell lower the risk of Proliferation Encourages differentiation of T Promotion cells into Th2 and of Th2 and Treg subsets.
Direct Treg supporting antieffect Responses responses and immune tolerance.
Cells Suppresses proInhibition of inflammatory Th1 Th1 and and Th17 activity.
Th17 which are associated Responses with autoimmune Modulation Inhibits dendritic cell of Antigen maturation and Indirect Presentation function, thereby Effects Dendritic inflammatory T cell Cells Inhibits differentiation of B B Cell cells into plasma Differentiation cells, reducing the risk of autoantibody Limits excessive expansion of B cells.
Inhibition of B Cell autoreactive B cells Proliferation that can trigger Cells Suppresses Inhibition of production, including Immunoglobulin autoantibodies that Production may damage body Enhances B cell tolerance to selfModulation of B Cell antigens, helping to Tolerance prevent autoimmune Cell Target Heme.
Vol VII No 2 May 2025 Impact on Autoimmune Diseases Reduces production in conditions such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
THERAPEUTIC POTENTIAL OF VITAMIN
D SUPPLEMENTATION FOR INFLAMMATORY
DISORDERS
Numerous studies have explored the relationship between vitamin D status and its impact on health outcomes, particularly in the context of acute infections and chronic inflammatory diseases such as abdominal obesity, insulin resistance, type 2 diabetes and hypertension.
A growing body of evidence suggests that individuals with lower levels of vitamin D are at increased risk for developing severe acute infections, and they tend to experience poorer clinical outcomes compared to those with adequate vitamin D This has prompted investigations into the potential of vitamin D supplementation as an adjunctive therapy to improve immune function and enhance recovery from Specifically, vitamin D is known to play a critical role in modulating the immune system, influencing the activity of both innate and adaptive immune responses.
bolstering these immune pathways, vitamin D supplementation could theoretically help patients better combat infectious agents, reduce the severity of symptoms, and expedite recovery.
Clinical studies have supplementation can significantly enhance immune responses during respiratory infections, such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis even acute lung injury/acute respiratory distress syndrome and COVID-19, where it can potentially reduce the risk of complications and improve survival rates.
In addition to its role in acute infections, vitamin D deficiency is commonly observed in individuals suffering from chronic atherosclerosis-related disease, inflammatory bowel disease, chronic kidney disease, and nonalcoholic fatty liver Low vitamin D levels in these pathogenesis of the diseases by influencing various inflammatory pathways.
Vitamin D has been shown to affect the expression of cytokines, immune cells, and other key components of the inflammatory response, suggesting that insufficient levels of vitamin D could exacerbate chronic inflammation, thereby promoting disease progression.
The connection between vitamin D deficiency and these diseases is multifactorial, with vitamin D potentially affecting not only immune modulation but also vascular health, insulin resistance, and liver function.
This pleiotropic role underscores the importance of maintaining sufficient vitamin D levels in Despite the well-established link between vitamin D deficiency and these diseases, the clinical utility of vitamin D supplementation remains a subject of debate.
In the broader community, vitamin D deficiency is alarmingly prevalent, with studies indicating that a significant portion of the populationAi particularly the elderly, individuals with limited sun exposure, and those with certain chronic conditionsAihas insufficient levels of vitamin D.
This deficiency is even more pronounced in critically ill patients, where it has been associated with a range of poor outcomes, including increased mortality, prolonged ICU stays, and higher rates of However, while observational studies have highlighted the association between low vitamin D levels and severe illness requiring ICU admission, there remains no conclusive evidence establishing a causal relationship.
In particular.
Health and Medical Journal HEME.
Vol VII No 2 May 2025 randomized controlled trials (RCT.
of vitamin D supplementation in critically ill populations have yielded mixed results.
Despite initial hopes that vitamin D could improve clinical outcomes in these patients.
RCTs have generally failed to show significant benefits.
These trials suggest that while vitamin D may play a role in modulating the immune and inflammatory response, its supplementation alone is insufficient to alter the trajectory of critical The lack of consistent findings from clinical trials points to the complexity of vitamin D's role in health and underscores the need for further research to elucidate its precise mechanisms of action and to identify optimal treatment strategies for patients with vitamin D deficiency.
The challenge lies in determining the right dosage, timing, and patient selection, particularly in critically ill populations, where the pathophysiology is often multifactorial and complex.
Ultimately, more robust evidence is needed to justify routine vitamin D supplementation as a therapeutic approach in critically ill i.
CONCLUSIONS
In conclusion.
Despite the promising research on Vitamin DAos effects on various immune cells, significant gaps remain.
Many studies focus on specific immune cell subsets in isolation, leaving the broader systemic effects of Vitamin D unclear.
Additionally, while animal studies and small human trials suggest positive outcomes, large-scale randomized controlled trials (RCT.
with diverse populations are lacking.
Research is also needed to determine the optimal dosing regimens for Vitamin D supplementation, particularly in populations with varying baseline levels of Vitamin D deficiency.
Addressing these gaps could significantly advance our understanding of how Vitamin D can be used therapeutically to modulate inflammation in clinical settings.
Email : heme@unbrah.
Vitamin D plays a multifaceted role in controlling inflammation through its effects on various immune cells, including macrophages, dendritic cells.
T cells, and B While existing studies offer strong evidence of Vitamin DAos anti-inflammatory potential, more research is necessary to address the gaps in understanding its longterm effects, optimal dosage, and populationspecific responses.
By focusing on these areas, future research could provide more definitive guidance on the use of Vitamin D in managing inflammation and autoimmune LIMITATION One of the limitations of this review is that the majority of the included studies are preclinical or observational in nature, which may limit the generalizability of the findings to clinical practice.
Additionally, there is considerable heterogeneity in the doses of vitamin D used across studies, and no standardized guidelines currently exist regarding the optimal dosage for managing inflammatory clinical conditions.
Therefore, further well-designed clinical trials are necessary to establish effective and evidence-based vitamin D supplementation protocols in the context of inflammation.
ACKNOWLEDGEMENTS
This work is part of research project, funded by Direktorat Riset.
Teknologi, dan Pengabdian kepada Masyarakat.
Direktorat Jenderal Pendidikan Tinggi.
Riset, dan Teknologi.
Kementerian Pendidikan.
Kebudayaan.
Riset, dan Teknologi Republik Indonesia, 2024.
REFERENCE